Merial is a successful and growing company devoted to animal health, intensely focused on developing and delivering breakthrough products. Merial believes that innovation is the principal competitive advantage in the pharmaceutical industry. Maximum value can only be created through breakthrough R&D, both from internal discoveries and from external research and commercial collaborations.

Merial strongly believes in 'win-win' collaborations with benefits accruing to both parties in an equitable fashion. Product candidates coming from outside collaborations are fully integrated into Merial’s development process. External opportunities receive the same standard of rigor and resources as internally discovered candidates.

What We Bring to Our Collaborations

Merial is a leader in the Animal Health industry. We hold the number one position in many markets and categories. As a result we bring enormous strength to all collaborations from leading scientists, operational excellence, distribution leverage and marketing to a deep understanding of the regulatory environment and product positioning.

Why consider Animal Health for licensing?

The animal health industry can provide important product extensions and additional revenue sources for life science technologies. The industry will often provide a significant amount of data for registration and a shorter route to market (depending on species and the region). As an example, there are more than 15 recombinant vaccines licensed in animal health. In fact, the first DNA vaccine was produced in our industry and launched in mid 2005.